Guadagno di sopravvivenza dei nuovi farmaci-Reference-Cited by-同舟云学术

Guadagno di sopravvivenza dei nuovi farmaci

Published:2004-07 Issue:2 Volume:6 Page:95-104
ISSN:1590-9158
Container-title:PharmacoEconomics Italian Research Articles
language:it
Short-container-title:Pharmacoeconomics-Ital-Res-Articles

Author:

Messori Andrea,Santarlasci B.,Trippoli S.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Health Policy

Link

http://link.springer.com/content/pdf/10.1007/BF03320627.pdf

Reference37 articles.

1. Wright JC, Weinstein MC. Gains in life expectancy from medical interventions: standardizing data on outcomes. N Engl J Med 1998; 339: 380–6

2. Messori A, Becagli P, Trippoli S. Median versus mean lifetime survival in the analysis of survival data. Haematologica 1997; 82(6): 730

3. Messori A, Trippoli S, Vaiani M. Cost-effectiveness of innovative anti-cancer drugs (Letter). eBMJ, 5 August 2002, web address: http://bmj.com/cgi/eletters/325/7358/269#24426

4. Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon alpha-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 1994; 330: 820–25

5. Messori A. Cost-effectiveness of interferon in chronic myeloid leukaemia: analysis of four clinical studies. Ann Oncol 1998; 9(4): 389–96

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic value of diastasis repair with the use of mesh compared to no intervention in Italy;The European Journal of Health Economics;2024-03-14

2. Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy;Advances in Therapy;2024-02-08

3. Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention;Expert Review of Pharmacoeconomics & Outcomes Research;2023-08-28

4. Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy;PharmacoEconomics;2023-01-20

5. Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma;Frontiers in Oncology;2022-08-29